HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul J Gomes Selected Research

Allergic Conjunctivitis (Giant Papillary Conjunctivitis)

8/2022Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial.
1/2021Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis.
1/2019Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects.
1/2018Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis.
1/2018Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model.
1/2017Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
1/2014Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.
5/2012Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.
8/2011Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
6/2011Antihistamines in ocular allergy: are they all created equal?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul J Gomes Research Topics

Disease

18Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
08/2022 - 08/2004
17Pruritus (Itching)
08/2022 - 08/2004
5Hypersensitivity (Allergy)
01/2019 - 07/2008
3Rhinorrhea
01/2018 - 05/2005
3Hyperemia
08/2011 - 09/2009
1Cataract (Cataracts)
01/2018
1Conjunctivitis
01/2018
1Strabismus (Squint)
01/2018
1Allergic Rhinitis
01/2016
1Sneezing
05/2005

Drug/Important Bio-Agent (IBA)

13AllergensIBA
01/2021 - 07/2007
13Ophthalmic Solutions (Eye Drops)IBA
01/2019 - 08/2004
7bepotastine besilateFDA Link
01/2018 - 09/2009
5Histamine Antagonists (Antihistamines)IBA
01/2018 - 07/2008
5Olopatadine Hydrochloride (Patanol)FDA Link
11/2008 - 08/2004
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2017
2Cetirizine (Zyrtec)FDA LinkGeneric
01/2019 - 01/2018
2Pharmaceutical PreparationsIBA
01/2019 - 08/2011
2Mast Cell StabilizersIBA
11/2008 - 07/2008
1reproxalapIBA
08/2022
1AldehydesIBA
08/2022
1iodixanol (Visipaque)FDA Link
01/2019
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
01/2018
1ragweed pollenIBA
01/2016
1Immunoglobulin E (IgE)IBA
05/2012
1Nasal SpraysIBA
11/2008
1SteroidsIBA
11/2008
1fluticasone furoateFDA Link
11/2008
1SolutionsIBA
11/2008
1ketotifen fumarate ophthalmic solution (Zaditor)FDA Link
07/2008
1Aligeron (AS 2)IBA
08/2004

Therapy/Procedure

1Lasers (Laser)
01/2018